ACC Action Center
Welcome to the ACC Action Center, bringing you the latest updates from the American College of Cardiology’s Annual Scientific Session & Expo, hosted in partnership with the World Congress of Cardiology. This collection will highlight emerging clinical data and explore the latest practice-changing advances in the field of cardiology.
61-67 of 67
Study with ASO Targeting ANGPTL3 mRNA Highlights Importance of Rigorous Evaluation of New Therapies
ACC Action CenterStudy with ASO Targeting ANGPTL3 mRNA Highlights Importance of Rigorous Evaluation of New Therapies
Reduction of Bleeding with Tranexamic Acid After Noncardiac Surgery
ACC Action CenterReduction of Bleeding with Tranexamic Acid After Noncardiac Surgery
Cardiac Myosin Inhibitor Sustainably Reduces LVOT Gradient in HCM
ACC Action CenterCardiac Myosin Inhibitor Sustainably Reduces LVOT Gradient in HCM
Impact of New First-in-Class Medical Therapy in Obstructive HCM
ACC Action CenterImpact of New First-in-Class Medical Therapy in Obstructive HCM
Treatment of Chronic Hypertension Reduces Adverse Pregnancy Outcomes
ACC Action CenterTreatment of Chronic Hypertension Reduces Adverse Pregnancy Outcomes
Updates in the New AHA/ACC/HFSA Heart Failure Guideline
ACC Action CenterUpdates in the New AHA/ACC/HFSA Heart Failure Guideline
- advertisement
Cardiac Myosin Inhibitor Reduces Need for Septal Reduction Therapy in Obstructive HCM
ACC Action CenterCardiac Myosin Inhibitor Reduces Need for Septal Reduction Therapy in Obstructive HCM
